Gender-related Distribution of the Interleukin-1β and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients with End-stage Liver Disease

By Fontanini Elisabetta   Cussigh Annarosa   Fabris Carlo   Falleti Edmondo   Toniutto Pierluigi   Bitetto Davide   Cmet Sara   Fumolo Elisa   Fornasiere Ezio   Bignulin Sara   Pinato David   Minisini Rosalba   Pirisi Mario  

Inflammation, Vol. 33, Iss. 4, 2010-08 ,pp. : 251-258

Springer Publishing Company

Access to resources Recommend Favorite

MELDEQ: An alternative Model for End‐Stage Liver Disease score for patients with hepatocellular carcinoma

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 5, 2015-05 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delayed hepatocellular carcinoma model for end‐stage liver disease exception score improves disparity in access to liver transplant in the United States

By  

HEPATOLOGY, Vol. 61, Iss. 5, 2015-05 ,pp. : 1643-1650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discrepancy of interleukin-6 levels between end-stage renal disease patients and patients with acute-phase response with increased lipoprotein(a) concentrations

By Yun K. A.   Lee W.   Min W. K.   Chun S.   Lee Y. W.   Kim S. B.   Park J. S.   Yang W. S.   Park H.   Hwang S. H.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 64, Iss. 3, 2004-06 ,pp. : 223-228

Informa Healthcare

Access to resources Recommend Favorite

Obesity is independently associated with infection in hospitalised patients with end‐stage liver disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 11-12, 2015-12 ,pp. : 1271-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite